Immunotherapy
-
Randomized Controlled Trial Multicenter Study
Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.
To determine the optimal effective and safe dose of sublingual immunotherapy tablets containing carbamylated monomeric allergoids in patients with grass pollen-induced allergic rhinoconjunctivitis. ⋯ This study found 1000 UA/day to be the optimal effective and safe dose.